Cargando…

Ertapenem-Induced Thrombocytosis

Ertapenem is a β-lactam antibiotic that has a broad spectrum of anti-microbial coverage. Hematological adverse events like thrombocytosis, neutropenia, and neutropenia are infrequent. Here we report a rare case of drug-induced thrombocytosis in a 68-year-old female, who was treated with ertapenem fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Docobo, Ramon A, Bukhari, Sumera, Qutrio Baloch, Zulfiqar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476495/
https://www.ncbi.nlm.nih.gov/pubmed/28652947
http://dx.doi.org/10.7759/cureus.1263
_version_ 1783244606391975936
author Docobo, Ramon A
Bukhari, Sumera
Qutrio Baloch, Zulfiqar
author_facet Docobo, Ramon A
Bukhari, Sumera
Qutrio Baloch, Zulfiqar
author_sort Docobo, Ramon A
collection PubMed
description Ertapenem is a β-lactam antibiotic that has a broad spectrum of anti-microbial coverage. Hematological adverse events like thrombocytosis, neutropenia, and neutropenia are infrequent. Here we report a rare case of drug-induced thrombocytosis in a 68-year-old female, who was treated with ertapenem for the diagnosis of complicated abdominal infection. This case emphasizes that any patient with thrombocytosis should be assessed with a careful and detailed history with consideration for possible drug side effects.
format Online
Article
Text
id pubmed-5476495
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-54764952017-06-26 Ertapenem-Induced Thrombocytosis Docobo, Ramon A Bukhari, Sumera Qutrio Baloch, Zulfiqar Cureus Oncology Ertapenem is a β-lactam antibiotic that has a broad spectrum of anti-microbial coverage. Hematological adverse events like thrombocytosis, neutropenia, and neutropenia are infrequent. Here we report a rare case of drug-induced thrombocytosis in a 68-year-old female, who was treated with ertapenem for the diagnosis of complicated abdominal infection. This case emphasizes that any patient with thrombocytosis should be assessed with a careful and detailed history with consideration for possible drug side effects. Cureus 2017-05-19 /pmc/articles/PMC5476495/ /pubmed/28652947 http://dx.doi.org/10.7759/cureus.1263 Text en Copyright © 2017, Docobo et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oncology
Docobo, Ramon A
Bukhari, Sumera
Qutrio Baloch, Zulfiqar
Ertapenem-Induced Thrombocytosis
title Ertapenem-Induced Thrombocytosis
title_full Ertapenem-Induced Thrombocytosis
title_fullStr Ertapenem-Induced Thrombocytosis
title_full_unstemmed Ertapenem-Induced Thrombocytosis
title_short Ertapenem-Induced Thrombocytosis
title_sort ertapenem-induced thrombocytosis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476495/
https://www.ncbi.nlm.nih.gov/pubmed/28652947
http://dx.doi.org/10.7759/cureus.1263
work_keys_str_mv AT docoboramona ertapeneminducedthrombocytosis
AT bukharisumera ertapeneminducedthrombocytosis
AT qutriobalochzulfiqar ertapeneminducedthrombocytosis